These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12063231)

  • 1. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.
    Rovira A; Pericot I; Alonso J; Rio J; Grivé E; Montalban X
    AJNR Am J Neuroradiol; 2002; 23(6):989-94. PubMed ID: 12063231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    Cianfoni A; Niku S; Imbesi SG
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
    Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
    Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.
    Sener RN
    AJNR Am J Neuroradiol; 2003 Sep; 24(8):1690-3. PubMed ID: 13679293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
    De Stefano N; Dotti MT; Mortilla M; Federico A
    Brain; 2001 Jan; 124(Pt 1):121-31. PubMed ID: 11133792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study.
    Nicoli F; Lefur Y; Denis B; Ranjeva JP; Confort-Gouny S; Cozzone PJ
    Stroke; 2003 Jul; 34(7):e82-7. PubMed ID: 12817104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
    Bitsch A; Bruhn H; Vougioukas V; Stringaris A; Lassmann H; Frahm J; Brück W
    AJNR Am J Neuroradiol; 1999 Oct; 20(9):1619-27. PubMed ID: 10543631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience.
    Eichler FS; Itoh R; Barker PB; Mori S; Garrett ES; van Zijl PC; Moser HW; Raymond GV; Melhem ER
    Radiology; 2002 Oct; 225(1):245-52. PubMed ID: 12355012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoencephalopathy, cerebral calcifications, and cysts: new observations.
    Nagae-Poetscher LM; Bibat G; Philippart M; Rosemberg S; Fatemi A; Lacerda MT; Costa MO; Kok F; Costa Leite C; Horská A; Barker PB; Naidu S
    Neurology; 2004 Apr; 62(7):1206-9. PubMed ID: 15079028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible decreases in N-acetylaspartate after acute brain injury.
    De Stefano N; Matthews PM; Arnold DL
    Magn Reson Med; 1995 Nov; 34(5):721-7. PubMed ID: 8544693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR spectroscopic findings in a case of Alpers-Huttenlocher syndrome.
    Flemming K; Ulmer S; Duisberg B; Hahn A; Jansen O
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1421-3. PubMed ID: 12223390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Predictive Values of Magnetic Resonance Biomarkers Based on Scan Timing in Neonatal Encephalopathy Following Therapeutic Hypothermia.
    Shibasaki J; Niwa T; Piedvache A; Tomiyasu M; Morisaki N; Fujii Y; Toyoshima K; Aida N
    J Pediatr; 2021 Dec; 239():101-109.e4. PubMed ID: 34391766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
    Richards TL
    AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging and proton magnetic resonance spectroscopy in perinatal hypoxic-ischemic encephalopathy: association with neuromotor outcome at 18 months of age.
    Khong PL; Tse C; Wong IY; Lam BC; Cheung PT; Goh WH; Kwong NS; Ooi GC
    J Child Neurol; 2004 Nov; 19(11):872-81. PubMed ID: 15658792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.